Clinical trial
Investigating the Therapeutic Effectiveness of Aloe Barbadensis in Reducing…
NCT00156806 · AHS Cancer Control Alberta, Other · Completed
Key facts
| NCT number | NCT00156806 |
|---|---|
| Title | Investigating the Therapeutic Effectiveness of Aloe Barbadensis in Reducing Cutaneous Side-Effects of Radiation Treatment for Breast Cancer. |
| Official title | Investigating the Therapeutic Effectiveness of Aloe Barbadensis in Reducing Cutaneous Side-Effects of Radiation Treatment for Breast Cancer. |
| Lead sponsor | AHS Cancer Control Alberta, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Procedure |
| Interventions | Aloe barbadensis topical application in a moisturizing cream vehicle. |
| Enrollment | 231 |
| Start date | Mar 1, 2002 |
| Primary completion | May 1, 2005 |
| Completion | May 1, 2006 |
| First posted | Sep 12, 2005 |
| Last update posted | Jan 24, 2017 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: